Thrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis

dc.authoridArat, Mutlu/0000-0003-2039-8557|Dalva, Klara/0000-0001-6917-6870|Beksac, Meral/0000-0003-1797-8657;
dc.contributor.authorAkan, H
dc.contributor.authorGüven, N
dc.contributor.authorAydogdu, I
dc.contributor.authorArat, M
dc.contributor.authorBeksaç, M
dc.contributor.authorDalva, K
dc.date.accessioned2025-10-24T18:09:27Z
dc.date.available2025-10-24T18:09:27Z
dc.date.issued2000
dc.departmentMalatya Turgut Özal Üniversitesi
dc.description.abstractIron deficiency anemia is a cause of reactive thrombocytosis. A moderate increase in platelet numbers is common but sometimes counts may exceed 1,000 x 10(9)/1. The mechanisms causing reactive thrombocytosis are unclear. In this study, we evaluated 15 women with iron deficiency anemia and thrombocytosis (platelets >450 x 10(9)/1) and 16 women with iron deficiency anemia with normal platelet counts. Serum samples were taken before oral iron replacement therapy, after 1 and 3 months and at the end of replacement therapy. Thrombopoietin, erythropoietin (EPO), leukemia inhibitory factor, interleukin-6 and interleukin-11 levels were assayed. There was no change in the levels of thrombopoietic cytokines except for EPO. The correlation between high EPO levels and high platelet counts may suggest that EPO increases platelet counts, but the same EPO revel changes can also be demonstrated in women with iron deficiency anemia but normal initial platelet counts. The fact that the levels of other cytokines remained unchanged during treatment suggests that either these cytokines have no effect on reactive thrombocytosis or the change in platelet counts in our patients is in a narrow range and is thus not affected by the cytokine levels. Copyright (C) 2000 S. Karger AG, Basel.
dc.identifier.doi10.1159/000041038
dc.identifier.endpage156
dc.identifier.issn0001-5792
dc.identifier.issn1421-9662
dc.identifier.issue3
dc.identifier.pmid10940653
dc.identifier.startpage152
dc.identifier.urihttps://doi.org/10.1159/000041038
dc.identifier.urihttps://hdl.handle.net/20.500.12899/3661
dc.identifier.volume103
dc.identifier.wosWOS:000088768000004
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherKarger
dc.relation.ispartofActa Haematologica
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_20251023
dc.subjecterythropoietin; interleukin 6; interleukin 11; iron deficiency anemia; leukemia inhibitory factor; thrombopoietin
dc.titleThrombopoietic cytokines in patients with iron deficiency anemia with or without thrombocytosis
dc.typeArticle

Dosyalar